Shilpa Medicare gets Health Canada GMP approval for Jadcherla facility Ruchika Sharma5 Dec 2022 12:30 PM ISTKarnataka: Shilpa Medicare has recently announced that the Company's finished dosage form manufacturing facility, Unit IV, situated at Pharma...
Shilpa Medicare Hyderabad division gets USFDA clearance Ruchika Sharma23 Sept 2022 12:15 PM ISTThe USFDA clearance on the facility will enable the company to test and release batches into the US from this facility.
Shilpa Medicare bags CDSCO nod for topical hemostatic spray of Tranexamic Acid Ruchika Sharma22 Sept 2022 2:59 PM ISTThe product is protected by granted patents in India till 2037 and in US, Australia, Russia and South Africa till 2038.
Shilpa Medicare gets USFDA nod for Tenofovir Alafenamide Tablets Ruchika Sharma19 Sept 2022 11:25 AM ISTNew Delhi: Shilpa Medicare has recently announced that the Company has received U.S Food and Drug Administration (USFDA) tentative approval for...
Shilpa Medicare Raichur facility gets Russian GMP certificate Ruchika Sharma20 July 2022 11:14 AM ISTHyderabad: Shilpa Medicare Limited has recently announced that the Company's API facility (unit-1) located at Raichur, Karnataka has received...
Shilpa Medicare gets 4 USFDA observations for Hyderabad division Ruchika Sharma2 May 2022 2:56 PM ISTHyderabad: After a recent inspection, the U.S. Food and Drug Administration (USFDA) has issued four observations to Shilpa Medicare's recently...
Shilpa Biologicals gets NoC to conduct trials of biosimilar Aflibercept Ruchika Sharma26 April 2022 3:55 PM ISTBiosimilar Aflibercept is the second biosimilar product from SML that has entered the clinical trial phase after Biosimilar Adalimumab.
Shilpa Biologics, Mylab ink pact to enter vaccine, therapeutics segment Ruchika Sharma11 Feb 2022 3:59 PM ISTNew Delhi: Mylab Discovery Solutions announced its foray into the vaccine and therapeutics segment with its strategic tie-up with Shilpa Biologicals...
Shilpa Medicare clears USFDA review for Dabaspet facility Ruchika Sharma20 Nov 2021 1:02 PM ISTHyderabad: Shilpa Medicare Limited has recently announced that United States Food and Drug Administration (USFDA) has concluded Remote Record Review...
Shilpa Medicare, Cadila ink pact for production of ZyCoV-D vaccine Ruchika Sharma25 Sept 2021 1:08 PM ISTHyderabad: Shilpa Medicare Limited, via its wholly owned subsidiary, Shilpa Biologicals Pvt Ltd (SBPL), has entered into a definitive agreement with...
Shilpa Medicare gets WHO-Geneva nod for API Praziquental to treat blood, liver fluke Ruchika Sharma31 July 2021 10:00 AM ISTBengaluru: Shilpa Medicare Limited has recently announced that the company has received confirmation from WHO-Geneva for prequalification of Active...
Shilpa Medicare gets WHO-Geneva nod for API, Tenofovir Disoproxil Fumarate for HIV, Hepatitis B Ruchika Sharma30 July 2021 12:00 PM ISTKarnataka: Shilpa Medicare Limited has recently announced the receipt of confirmation of WHO - GENEVA approval for API, Tenofovir Disoproxil...
